• Resiniferatoxin (RTX): Redefining Osteoarthritis Pain Interv

  2026-06-23

  Explore how Resiniferatoxin (RTX) enables precise, long-lasting pain management in osteoarthritis through targeted TRPV1 inactivation. This article provides a deep dive into RTX's clinical promise, advanced mechanisms, and practical assay considerations beyond existing reviews.

• (+)-Bicuculline: Protocol Parameters and Workflow in Neurosc

  2026-06-22

  (+)-Bicuculline is a GABAA receptor antagonist essential for dissecting inhibitory neurotransmission and synaptic NMDA receptor signaling in neuroscience research. It is not suitable for diagnostic or clinical applications and requires adherence to solubility, storage, and workflow guidelines to ensure reproducibility.

• Angiotensin II: Mechanistic Insights for AAA and Vascular Re

  2026-06-22

  This thought-leadership article explores the pivotal role of Angiotensin II in modeling abdominal aortic aneurysm (AAA) and vascular remodeling, blending mechanistic understanding with actionable guidance for translational researchers. Drawing on recent breakthroughs in cellular senescence biomarkers and integrating both experimental protocols and strategic outlooks, we demonstrate how APExBIO’s Angiotensin II enables cutting-edge studies in cardiovascular disease. This piece uniquely bridges biological rationale, experimental best practices, and translational vision—surpassing conventional product guides.

• CHIR 99021 Trihydrochloride: Unlocking Dynamic Control in Or

  2026-06-21

  Explore how CHIR 99021 trihydrochloride, a leading GSK-3 inhibitor, enables tunable self-renewal and differentiation in organoid research. Discover fresh insights on assay optimization, protocol selection, and practical implications for stem cell and metabolic disease modeling.

• Sabutoclax: Pan-Bcl-2 Inhibitor Workflows for Cancer Apoptos

  2026-06-20

  Sabutoclax empowers oncology researchers through potent, multi-targeted inhibition of Bcl-2 family proteins, enabling precise and reproducible apoptosis assays in both in vitro and in vivo models. Its superior cell permeability and selectivity facilitate advanced experimental workflows and troubleshooting not possible with earlier inhibitors.

• Rapamycin (Sirolimus): mTOR Inhibition and Autophagy Pathway

  2026-06-19

  Explore how Rapamycin (Sirolimus) modulates mTOR signaling and autophagic-lysosomal pathways in neurodegeneration models. This article uniquely bridges molecular mechanism, assay design, and translational insights for advanced research applications.

• Multi-Omics Dissection of HSYC's Anti-Ovarian Aging Effects

  2026-06-19

  This study leverages multi-omics analysis to reveal how He's Yangchao formula (HSYC) ameliorates ovarian aging in naturally aged mice, with a focus on glutathione metabolism and mitochondrial function. These findings highlight the complex, multi-pathway mechanisms by which traditional herbal medicines may preserve reproductive health and offer a model for integrating gut microbiota and metabolic profiling in aging research.

• Oleanolic Acid: Unraveling iNOS and COX-2 Modulation in Next

  2026-06-18

  Explore the scientific foundation of oleanolic acid as an inducible nitric oxide synthase-inducing antiviral research compound. This article uniquely examines how its mechanism of action and solubility profile enable robust, reproducible immune modulation assays, bridging molecular pharmacology with advanced nanoliposome technologies.

• MEK1/2-ERK1/2 Pathway Drives Lung Hemorrhage in Lupus Mice

  2026-06-18

  This study demonstrates that activation of the MEK1/2-ERK1/2 signaling cascade is a central driver of diffuse alveolar hemorrhage (DAH) in a murine lupus model. Selective inhibition of MEK1/2 or ERK1/2 normalized endothelial injury and hemostatic imbalance, highlighting new mechanistic links and potential intervention points for severe lupus-associated lung injury.

• 8-Chloroadenosine: Mechanism-Driven Innovation in Translatio

  2026-06-17

  This thought-leadership article unpacks the mechanistic underpinnings and strategic applications of 8-Chloroadenosine as a nucleoside analog for transcriptional regulation and RNA metabolism studies. We synthesize recent NSCLC lncRNA research, position APExBIO’s reagent in the competitive landscape, and offer actionable guidance for translational researchers aiming to bridge molecular insight with therapeutic innovation.

• ALDH2 Activation Promotes Cardiomyocyte Proliferation in Hea

  2026-06-17

  This study demonstrates that activating ALDH2 in mice promotes cardiomyocyte proliferation and delays heart failure onset during ventricular pressure overload. These findings reveal a novel regenerative pathway for cardiac repair, highlighting ALDH2 as a promising target for cardiac ischemia research.

• Ciprofloxacin Modulates Ferroptosis via Mitochondrial Zinc P

  2026-06-16

  This study reveals a previously unrecognized mechanism by which ciprofloxacin amplifies RSL3-induced ferroptosis in cancer cells, acting through mitochondrial zinc accumulation and the STING1–CAV2 pathway. These findings provide a nuanced understanding of ferroptosis regulation and may inform targeted therapeutic strategies in oncology.

• Optimizing Cardiovascular Assays with Fosinopril Sodium (SKU

  2026-06-16

  This article delivers a scenario-driven, evidence-based guide for labs using Fosinopril sodium (SKU A4079) in cell viability, proliferation, and cytotoxicity assays. It addresses real bench challenges—such as ACE inhibitor solubility, reproducibility, and vendor reliability—highlighting how APExBIO's offering streamlines cardiovascular disease modeling with validated performance and transparent data.

• URB597 (KDS-4103): Precision FAAH Inhibition in Neuroresearc

  2026-06-15

  URB597, also known as KDS-4103, is a potent and selective FAAH inhibitor widely used for in vivo endocannabinoid signaling modulation. It elevates anandamide levels in the brain with high specificity, providing a robust tool for neuroplasticity and neuroinflammation research applications.

• CD98hc Orchestrates CNS Angiogenesis and Blood–Brain Barrier

  2026-06-15

  This study uncovers the central role of CD98hc in regulating angiogenesis and blood–brain barrier (BBB) integrity within the central nervous system (CNS). Through genetic mouse models and in vitro assays, the research demonstrates that CD98hc modulates the integrin–FAK pathway in a CNS-specific manner, revealing new therapeutic avenues for cerebrovascular disease.

411 records 11/28 page Previous Next First page 上5页 1112131415 下5页 Last page